Literature DB >> 13532592

[Treatment of rheumatism with drug combinations].

W OSWALD.   

Abstract

Entities:  

Keywords:  PANTOTHENIC ACID/related compounds; RHEUMATISM/therapy; SALICYLIC ACID/therapeutic use

Mesh:

Substances:

Year:  1958        PMID: 13532592     DOI: 10.1007/BF01234170

Source DB:  PubMed          Journal:  Acta Neuroveg (Wien)        ISSN: 0375-9245


× No keyword cloud information.
  25 in total

1.  [The significance of the reaction type of the organism for the development and therapy of rheumatic joint disease].

Authors:  H SCHOLZ; C STEFFEN
Journal:  Klin Med Osterr Z Wiss Prakt Med       Date:  1954-11-01

2.  Salicylates in rheumatic fever; difficulties experienced in treating children with large doses.

Authors:  K S HOLT
Journal:  Lancet       Date:  1954-12-11       Impact factor: 79.321

3.  Cortisone and salicylates in rheumatic fever.

Authors:  K S HOLT; R S ILLINGWORTH; J LORBER; J RENDLE-SHORT
Journal:  Lancet       Date:  1954-12-04       Impact factor: 79.321

4.  [Treatment of rheumatism with drug combinations].

Authors:  W OSWALD
Journal:  Schweiz Med Wochenschr       Date:  1954-09-04

5.  [Thoughts and experiences in modern rheumatism therapy for the general practitioner].

Authors:  L CLOETTA
Journal:  Praxis       Date:  1954-06-24

6.  [The burning feet syndrome and its therapy].

Authors:  W OSWALD
Journal:  Ther Umsch       Date:  1953-11

7.  Rheumatoid arthritis and the liver.

Authors:  O LOVGREN
Journal:  Ann Med Intern Fenn       Date:  1953

8.  Sulfhydryl inhibition as a mechanism in effects of ACTH and cortisone.

Authors:  G E ANDERSON; L L WIESEL; R W HILLMAN; W M STUMPE
Journal:  Proc Soc Exp Biol Med       Date:  1951-04

9.  Hemorrhagic reactions.

Authors:  G SHWARTZMAN
Journal:  Bull Schweiz Akad Med Wiss       Date:  1952-02

10.  Renal clearance of pantothenic acid in man; inhibition by probenecid (benemid).

Authors:  W P BOGER; G M BAYNE; J GYLFE; L D WRIGHT
Journal:  Proc Soc Exp Biol Med       Date:  1953-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.